Rege Nephro Co., Ltd. is a clinical-stage biotech company developing treatments for kidney diseases, including Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease, using technology from Kyoto University's Center for iPS Cell Research and Application.

QSimulate develops quantum simulation technologies that enhance drug discovery processes, including lead optimization and inhibitor design, through its platform QSP Life and tools like QUELO, QuValent, and QuantumFP.